Roll-out of RSV vaccine and antibody treatment leads to massive drop in US hospitalisations
Data from the US Centers for Disease Control and Prevention suggests that the roll-out of preventive approaches has had an immediate impact on RSV rates.
Priya Joi is a British-Indian science writer based in Barcelona. She was previously a staff writer and editor at the World Health Organization, The Lancet, and New Scientist magazine. She has a degree in genetics.